Webinar | December 10, 2021

Clinical Trials In Rare Diseases

Source: THREAD

Developing therapies to treat rare diseases is a critical area of clinical research. However, the lack of natural history data and well-established clinical endpoints can result in complex clinical protocols that are unduly burdensome. Decentralized Clinical Trials (DCTs), provide an opportunity to transform participation in rare disease clinical trials. By moving from the traditional site-based model to DCT elements that can be brought to participants’ homes can reduce the overall study burden and improve the participant experience leading to better engagement and retention.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader